Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Claritev CorpMPLN · Entity 5238 | EVP, General Counsel | March 29, 2024 | April 01, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Claritev Corp
Report date March 29, 2024 · Filed April 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 1,532,000 |
Reported balance
After 2024-03-29 transaction · row 1
1 source rowRow 1 · 2024-03-29 · Tax withholding · Disposed 2,781 · Balance 1,532,000 F1: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld to pay taxes applicable to vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2024 Filed Apr 1, 2024 16:34 UTC | Claritev Corp MPLN · Entity 5238 | Tax withholdingClass A common stock | 2,781 | $0.81 | $2,252.61 |
DisclosureSEC source: 0001793229-24-000052 · wk-form4_1712003671.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,532,000 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:56 UTC | Claritev Corp MPLN · Entity 5238 | GrantClass A common stock | 364,865 | $1.11 | $405,000.15 |
DisclosureSEC source: 0001793229-24-000030 · wk-form4_1709675754.xml · nonDerivative · entry 3 Doctoroff Jeffrey · CIK 0001827263 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,534,781 F3 · kind: Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2025, 2026, 2027, and 2028. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:56 UTC | Claritev Corp MPLN · Entity 5238 | Tax withholdingClass A common stock | 63,247 | $1.11 | $70,204.17 |
DisclosureSEC source: 0001793229-24-000030 · wk-form4_1709675754.xml · nonDerivative · entry 2 Doctoroff Jeffrey · CIK 0001827263 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,169,916 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units granted on March 1, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:56 UTC | Claritev Corp MPLN · Entity 5238 | Tax withholdingClass A common stock | 8,436 | $1.11 | $9,363.96 |
DisclosureSEC source: 0001793229-24-000030 · wk-form4_1709675754.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,233,163 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units granted on March 1, 2022. Read SEC document |
| March 29, 2023 Filed Mar 30, 2023 16:49 UTC | Claritev Corp MPLN · Entity 5238 | Tax withholdingClass A common stock | 2,780 | $1.08 | $3,002.40 |
DisclosureSEC source: 0001793229-23-000045 · wf-form4_168020936806014.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,241,599 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:48 UTC | Claritev Corp MPLN · Entity 5238 | Tax withholdingClass A common stock | 24,026 | $0.90 | $21,623.40 |
DisclosureSEC source: 0001793229-23-000026 · wf-form4_167788007138294.xml · nonDerivative · entry 2 Doctoroff Jeffrey · CIK 0001827263 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,227,188 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:48 UTC | Claritev Corp MPLN · Entity 5238 | GrantClass A common stock | 819,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001793229-23-000026 · wf-form4_167788007138294.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,251,214 F1 · kind: Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2024, 2025, 2026, and 2027. Read SEC document |
| March 01, 2023 Filed Mar 15, 2023 16:49 UTC Amendment | Claritev Corp MPLN · Entity 5238 | Tax withholdingClass A common stock | 6,835 | $0.90 | $6,151.50 |
DisclosureSEC source: 0001793229-23-000035 · wf-form4a_167891336564860.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,244,379 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. F2 · shares: On March 3, 2023, the reporting person filed a Form 4 that, in the second transaction disclosed, contained an erroneous figure in the "Amount" sub-column of Column 4, entitled "Securities Acquired (A) or Disposed Of (D)." The erroneous amount was the total number of restricted stock units that vested on March 1, 2023, rather than just the shares withheld to pay taxes on such vesting. The correct amount of shares disposed of is 6,835 shares and, therefore, the correct figure in Column 5, entitled "Amount of Securities Beneficially Owned Following the Reported Transaction(s)," is 1,244,379 shares. This Form 4/A is filed to furnish the correct amounts. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 16:42 UTC | Claritev Corp MPLN · Entity 5238 | Tax withholdingClass A common stock | 3,315 | $4.66 | $15,447.90 |
DisclosureSEC source: 0001793229-22-000048 · wf-form4_164875927654553.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,143 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:45 UTC | Claritev Corp MPLN · Entity 5238 | GrantStock Option · Derivative | 180,677 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001793229-22-000033 · wf-form4_164634390483238.xml · derivative · entry 2 Doctoroff Jeffrey · CIK 0001827263 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,677 Underlying: Class A common stock, par value $0.0001 per share · 180,677 shares Expires 2032-03-01 F2 · derivative.exercise_date: The grant will vest, and become exercisable, at a rate of 25% per year on each of March 1, 2023, 2024, 2025 and 2026. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:45 UTC | Claritev Corp MPLN · Entity 5238 | GrantClass A common stock | 96,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001793229-22-000033 · wf-form4_164634390483238.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,458 F1 · shares: Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2023, 2024, 2025 and 2026. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 17:09 UTC | Claritev Corp MPLN · Entity 5238 | GrantStock Option · Derivative | 95,233 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0001793229-21-000047 · wf-form4_162465533963073.xml · derivative · entry 2 Doctoroff Jeffrey · CIK 0001827263 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,233 Underlying: Class A common stock, par value $0.0001 per share · 95,233 shares Expires 2031-06-23 F2 · derivative.exercise_date: The grant will vest, and become exercisable, at a rate of 25% per year on each of March 29, 2022, 2023, 2024 and 2025, subject to continued service through the respective vesting dates. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 17:09 UTC | Claritev Corp MPLN · Entity 5238 | GrantClass A common stock | 37,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001793229-21-000047 · wf-form4_162465533963073.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,353 F1 · shares: Represents a grant of restricted stock units. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 17:25 UTC | Claritev Corp MPLN · Entity 5238 | GrantClass A common stock | 301,464 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-028046 · doc4.xml · nonDerivative · entry 1 Doctoroff Jeffrey · CIK 0001827263 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,464 F1 · kind: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F1 · price: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.